Strategies and Case Studies of JAK-STAT Targeted Therapies
Strategies for Novel Autoimmune Drug Development: Preclinical Efficacy and Case Studies of JAK-STAT Targeted Therapies JAK Family Molecules: Central Hubs...
Continue ReadingKnowledge Library
Defining the Next Era of Cancer Therapeutics
Building on the momentum of AACR 2026, WuXi AppTec was honored to host an outstanding group of regional industry leaders...
Continue Reading
Defining the Next Era of Cancer Therapeutics
Building on the momentum of AACR 2026, WuXi AppTec was honored to host an exceptional group of regional industry leaders...
Continue Reading
Targeting ER Mutations and Drug Resistance
Targeting ER Mutations and Drug Resistance: R&D Strategies and Comprehensive Preclinical Evaluation of Novel ER Degraders Introduction Estrogen receptor (ER)-positive...
Continue Reading
α-Synuclein-Based Animal Models of Parkinson’s Disease
Establishment and Efficacy Evaluation of α-Synuclein-Based Animal Models of Parkinson’s Disease OncoWuXi Express will continue to keep you informed about...
Continue Reading
Overcoming Osteoporosis R&D Bottlenecks
Overcoming Osteoporosis R&D Bottlenecks with Multi-Dimensional OVX Models Against the backdrop of an actively aging global population, osteoporosis has emerged...
Continue Reading
PD-1 Blockade with a DLL3 TCE Potentiates Efficacy in SCLC
Small cell lung cancer (SCLC) remains one of the most aggressive and difficult-to-treat cancers, highlighting the ongoing need for new...
Continue Reading
Novel E3 Ligase to Support Targeted Protein Degradation
Targeted protein degradation (TPD) continues to expand the possibilities for next-generation therapeutics, and identifying novel E3 ligases remains an important...
Continue Reading
Mechanistic Profiling of ADC-resistant Cancer Cell Lines
Antibody-drug conjugates (ADCs) have emerged as an important modality in targeted cancer therapy development. However, acquired resistance continues to limit...
Continue Reading